Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: IND–BMT integration program | Statement: [Chrystie Street subway project, partOf, IND–BMT integration program]

Target entity: IND–BMT integration program
Context triple: [Chrystie Street subway project, partOf, IND–BMT integration program]

• A. BCMA
  BCMA (B-cell maturation antigen) is a cell-surface protein expressed on plasma cells and multiple myeloma cells that serves as a key target for immunotherapies such as CAR T-cell treatments.
• B. Kymriah
  Kymriah is a pioneering CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient’s own immune cells to target and destroy malignant cells.
• C. exagamglogene autotemcel
  Exagamglogene autotemcel is an investigational CRISPR/Cas9-based gene-editing therapy being developed to treat inherited blood disorders such as sickle cell disease and transfusion-dependent beta thalassemia.
• D. Cambridge Blood and Stem Cell Biobank
  The Cambridge Blood and Stem Cell Biobank is a major research facility that collects, processes, and stores human blood and stem cell samples to support biomedical and translational research.
• E. Ajmera Transplant Centre
  Ajmera Transplant Centre is a leading organ transplant facility within Toronto General Hospital, specializing in advanced multi-organ transplantation and related clinical care and research.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: IND–BMT integration program
Triple: [Chrystie Street subway project, partOf, IND–BMT integration program]

The IND–BMT integration program was a mid-20th-century New York City subway unification effort that physically and operationally linked the formerly separate IND and BMT divisions into a more cohesive rapid transit system.

Target entity: IND–BMT integration program
Target entity description: The IND–BMT integration program was a mid-20th-century New York City subway unification effort that physically and operationally linked the formerly separate IND and BMT divisions into a more cohesive rapid transit system.

• A. BCMA
  BCMA (B-cell maturation antigen) is a cell-surface protein expressed on plasma cells and multiple myeloma cells that serves as a key target for immunotherapies such as CAR T-cell treatments.
• B. Kymriah
  Kymriah is a pioneering CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient’s own immune cells to target and destroy malignant cells.
• C. exagamglogene autotemcel
  Exagamglogene autotemcel is an investigational CRISPR/Cas9-based gene-editing therapy being developed to treat inherited blood disorders such as sickle cell disease and transfusion-dependent beta thalassemia.
• D. Cambridge Blood and Stem Cell Biobank
  The Cambridge Blood and Stem Cell Biobank is a major research facility that collects, processes, and stores human blood and stem cell samples to support biomedical and translational research.
• E. Ajmera Transplant Centre
  Ajmera Transplant Centre is a leading organ transplant facility within Toronto General Hospital, specializing in advanced multi-organ transplantation and related clinical care and research.
• F. None of above. chosen